AU2002225895A1 - Hepatitis c virus constructs characterized by high efficiency replication - Google Patents
Hepatitis c virus constructs characterized by high efficiency replicationInfo
- Publication number
- AU2002225895A1 AU2002225895A1 AU2002225895A AU2589502A AU2002225895A1 AU 2002225895 A1 AU2002225895 A1 AU 2002225895A1 AU 2002225895 A AU2002225895 A AU 2002225895A AU 2589502 A AU2589502 A AU 2589502A AU 2002225895 A1 AU2002225895 A1 AU 2002225895A1
- Authority
- AU
- Australia
- Prior art keywords
- hepatitis
- high efficiency
- virus constructs
- constructs characterized
- replication
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/18—Togaviridae; Flaviviridae
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physiology (AREA)
- Communicable Diseases (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24586600P | 2000-11-07 | 2000-11-07 | |
US60/245,866 | 2000-11-07 | ||
PCT/US2001/046350 WO2002038793A2 (en) | 2000-11-07 | 2001-11-02 | Hepatitis c virus constructs characterized by high efficiency replication |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002225895A1 true AU2002225895A1 (en) | 2002-05-21 |
Family
ID=22928409
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002225895A Abandoned AU2002225895A1 (en) | 2000-11-07 | 2001-11-02 | Hepatitis c virus constructs characterized by high efficiency replication |
Country Status (3)
Country | Link |
---|---|
US (2) | US6930095B2 (en) |
AU (1) | AU2002225895A1 (en) |
WO (1) | WO2002038793A2 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6921634B2 (en) * | 1999-12-23 | 2005-07-26 | Board Of Regents, The University Of Texas System | Replication competent hepatitus C virus and methods of use |
JP4299540B2 (en) | 2001-01-23 | 2009-07-22 | イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・ピー・アー | Hepatitis C virus replicon and replicon enhanced cells |
FR2824072B1 (en) * | 2001-04-27 | 2004-03-12 | Centre Nat Rech Scient | PROCESS FOR REPLICATION AND PRODUCTION OF HEPATITIS C VIRUS |
DE602004024658D1 (en) | 2003-02-13 | 2010-01-28 | Merck & Co Inc | METHOD FOR TRANSFERRING CELL CULTURAL REPLICATION ACTIVITY TO DIFFERENT HEPATITIS C VIRUS ISOLATES |
US8354518B2 (en) | 2003-11-05 | 2013-01-15 | Merck Sharp & Dohme Corp. | HCV replicons containing NS5B from genotype 2B |
DK2423216T3 (en) * | 2003-12-01 | 2015-07-20 | Univ Texas | Replication-competent hepatitis C virus and methods of using |
CU23496A1 (en) * | 2004-09-03 | 2010-02-23 | Ct Ingenieria Genetica Biotech | VACCINE COMPOSITION AGAINST THE VIRUS OF HEPATITIS C |
EP1801116A1 (en) * | 2005-12-21 | 2007-06-27 | F. Hoffmann-La Roche Ag | HCV replicon shuttle vectors |
CN100371022C (en) * | 2006-05-10 | 2008-02-27 | 李卫云 | Method for establishing anti-hepatitis C virus drug screening experimental animal model |
GB0716292D0 (en) | 2007-08-21 | 2007-09-26 | Biofocus Dpi Ltd | Imidazopyrazine compounds |
US20100173281A1 (en) * | 2009-01-06 | 2010-07-08 | Roche Palo Alto Llc | HCV NS3 protease replicon shuttle vectors |
EP3201342A4 (en) | 2014-10-01 | 2018-07-25 | National Research Council of Canada | Animal models, cell lines and methods for screening hepatitis c virus vaccines |
CN106939300A (en) * | 2017-04-26 | 2017-07-11 | 中国医学科学院医学生物学研究所 | Tree shrew immortalized liver cell cell line and its construction method and application |
CN107312856B (en) * | 2017-07-24 | 2020-10-27 | 广州医科大学附属第一医院 | Primer pair, probe, kit and method for detecting common infection-related cytokines of tree shrew by fluorescent quantitative PCR (polymerase chain reaction) |
CN111440769B (en) * | 2020-02-25 | 2021-07-06 | 浙江大学 | Human hepatocyte hepatoma cell strain and application thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5679342A (en) | 1987-11-18 | 1997-10-21 | Chiron Corporation | Hepatitis C virus infected cell systems |
US6127116A (en) | 1995-08-29 | 2000-10-03 | Washington University | Functional DNA clone for hepatitis C virus (HCV) and uses thereof |
US5874565A (en) * | 1995-08-29 | 1999-02-23 | Washington University | Nucleic acids comprising a highly conserved novel 3 terminal sequence element of the hepatitis C virus |
US7049428B1 (en) * | 1998-03-04 | 2006-05-23 | Washington University | HCV variants |
DE19915178A1 (en) | 1999-04-03 | 2000-10-05 | Univ Mainz Johannes Gutenberg | Hepatitis C virus cell culture system |
MXPA03005638A (en) | 2000-12-22 | 2004-04-05 | Boehringer Ingelheim Ca Ltd | Self-replicating rna molecule from hepatitis c virus. |
-
2001
- 2001-11-02 WO PCT/US2001/046350 patent/WO2002038793A2/en not_active Application Discontinuation
- 2001-11-02 AU AU2002225895A patent/AU2002225895A1/en not_active Abandoned
- 2001-11-07 US US10/005,469 patent/US6930095B2/en not_active Expired - Lifetime
-
2005
- 2005-04-20 US US11/111,686 patent/US20050260221A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US6930095B2 (en) | 2005-08-16 |
US20020155133A1 (en) | 2002-10-24 |
US20050260221A1 (en) | 2005-11-24 |
WO2002038793A3 (en) | 2002-08-15 |
WO2002038793A9 (en) | 2003-02-13 |
WO2002038793A2 (en) | 2002-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001282528A1 (en) | Compounds having anti-hepatitis c virus effect | |
AU2002210450A1 (en) | Maintaining virus detection software | |
AU2002225895A1 (en) | Hepatitis c virus constructs characterized by high efficiency replication | |
AU2003206862A1 (en) | Hepatitis b vaccines | |
AU7087901A (en) | Modified virus | |
AU2001238401A1 (en) | Cold-adapted equine influenza viruses | |
AU2003294757A1 (en) | Formulations useful against hepatitis c virus infections | |
AU2002306709A1 (en) | Oncolytic rna replicons | |
AU2001278337A1 (en) | Respiratory syncytial virus vaccine | |
AU2002243257A1 (en) | Oncolytic virus | |
AU2002257890A1 (en) | Method for replicating the hepatitis C virus | |
AUPR160400A0 (en) | Plant virus promoter | |
GB0001475D0 (en) | Virus strains | |
GB0001476D0 (en) | Herpes virus strains | |
AU2003301865A1 (en) | Epitopes of hepatitis c virus | |
AU2003248821A1 (en) | Chimeric gb virus b (gbv-b) | |
AU2003227026A1 (en) | An infectious bursal disease virus variant | |
AU2001286111A1 (en) | Improvements to lasers | |
AU6551800A (en) | Dinucleoside 5',5'-tetraphosphates as inhibitors of viral reverse transcriptasesand viruses | |
AU2002222139A1 (en) | Hcv vaccines | |
AU2001229677A1 (en) | Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses | |
EP1290230A4 (en) | Hepatitis c virus conjugates | |
AU2003256404A1 (en) | Hepatitis c virus assays | |
AU2002224845A1 (en) | Viral expression system | |
AU4957800A (en) | Vaccine against isa virus |